 

ice-o,3

PATIENT HISTORY: . MW Wm Emmi/12H A, M05 8’} 80/3
CHIEF COMPLAINT/PREOPIPOSTOP. Endometrial mncer. S J {,6 Own -. MW‘I’AM» C 54 I

LMP: Postmenopausal. 4 u
PROCEDURE: Laparoscopic assisted vaginal hysterectomy. RSO, node sampling. left salpingectomy. /J/l > '

OUTSIDE DIAGNOSIS: No '
PRIOR MALIGNANCY: No

 

CHEMORADIATION THERAPY: No uum#:8653132-cAeigrlgil-‘aapaka-zzaoacacaaogdacted
OTHER DISEASES: No - - — -
a ‘ IIIIIII'IIIIIIIIII'IIIIIIIIIII'llIIIIIIIIIIIIIIIIIII'IIII”'“
Ill llllllllIlllllllllllllllllllllIIIIIIIIIIIIIIIIlllIIlIllIIIIII
FINAL DIAGNOSIS:

PART 1: UTERUS WITH RIGHT OVARY AND FALLOPIAN TUBE AND LEFT FALLOPIAN TUBE, LAPAROSCOPIC-ASSISTED
VAGINAL HYSTERECTOMY, RIGHT SALPINGO-OOPHORECTOMY AND LEFT SALPINGECTOMY (70 GRAMS) -
A. ENDOMETRIUM WITH POLYPOID MODERATELY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA

INVOLVING ABOUT 65% OF ENDOMETRIAEﬁUBEACE AND PENETRATI UP TO 80% OF MY
THICKNESS (1 C). (see mammal“)?~

UNINVOLVED ENDOMETRIUM IN PROLIFERATIVE PATTERN.

CHRONIC CYSTIC CERVICITIS WITH SQUAMOUS METAPLASIA AND PARAKERATOSIS.

RIGHT OVARY WITH SEROSAL ADHESIONS AND EPITHELIAL INCLUSIONS, NO TUMOR IS SEEN.
RIGHT FALLOPIAN TUBE, NO TUMOR SEEN.

LEFT FALLOPIAN TUBE, NO TUMOR SEEN.

 

71!“???

PART 2: LYMPH NODE, LEFT PELVIC, BIOPSY -
TWO LYMPH NODES, FREE OF TUMOR (OIZ).

PART 3: LYMPH MODES, RIGHT PELVIC, BIOPSY ~
TWO LYMPH NODES. FREE OF TUMOR (0/2).

PART 4: LYMPH NODES, LEFT PERIAORTIC, BIOPSY -
THREE LYMPH NODES, FREE OF TUMOR (0/3).

PART 5: LYMPH NODE, RIGHT PERIAORTIC, BIOPSY -
NO LYMPH NODE OR TUMOR IS SEEN.

PART 6: OMENTUM. BIOPSY -

OMENTUM WITH INFLAMMATION AND FIBROUS ADHESIONS. NO TUMOR SEEN.
J

COMMENT: “I...”

This endometn'oid adenocarcinoma represents-FIGO stage Ish'he peritoneal cytology Is negative for
“(w/f

malignant cells. ‘

The patients previous endometrial biopsy with endometrioid adenocarci'nomau noted. T“.—

The results of immunohistochemlcal stains l‘or D240 and C031, support the above diagnosis (see mlcroscoplc
description).

CASE SYNOPSIS:
SYNOPTIC - PRIMARY UTERINE ENDOMETRIAL CARCINOMA 8- CARCINOSARCOMA : HYSTERECTOMY
SPECIMENS
TUMOR TYPE: Endometroid adenocarcinoma, NOS

HISTOLOGIC GRADE (epithelial neoplasm) [combined architectural and nuclear]:
Moderately differentiated (FIGO 2)

ARCHITECTURAL GRADE: Moderately differentiated
NUCLEAR GRADE: Grade 2
TUMOR SIZE:

Maximum dimension: 4.8 mm
PERCENT OF ENDOMETRIAL SURFACE INVOLVEMENT:

Anterior endomyometrium: 90 %, Posterior endomyometrium: 40 °/n

DEPTH OF INVASION: Greater than ore ual to 1/2 thickn ss ofm om t'
ANGIOLYMPHATIC INVASION: No q a y erlum

LYMPH NODES POSITIVE: Number of lymph nodes positive:: 0

LYMPH MODES EXAMINED: Total number of lymph nodes examined: 7
T STAGE, PATHOLOGIC: pT1b

N STAGE, PATHOLOGIC: pNO
M STAGE, PATHOLOGIC: Not applicable
FIGO STAGE: IB

  
 
   
 
 
 

  

Tumor Site

 

HIPAA
Prior

  
 
 

use I:
Reviewer Initials

